Skip to Main Content

Paper Details

Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.
Ann Rheum Dis
15
2022
LDA, Patients, Systemic Lupus, Systemic Lupus Erythematosus, Systemic Lupus Erythematosus Disease, lupus, mLLDAS, patients, prednisone, systemic lupus erythematosus
Author NameAffiliation
Murray B UrowitzSchroeder Arthritis Institute, Krembil Research Institute, Toronto Western Hospital, University of Toronto
Paul R FortinCHU de Quebec - Universite Laval
Paul R FortinCHU de Quebec - Universite Laval
Dafna D GladmanSchroeder Arthritis Institute, Krembil Research Institute, Toronto Western Hospital, University of Toronto
Michelle PetriJohns Hopkins University School of Medicine
  • 1 - 5

Datasets

Release 1.2